/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

ANIK — Anika Therapeutics Inc

Nasdaq

Anika Therapeutics Inc

Back to Screener
$19.10
-0.26(-1.34%)
O
19.41
H
19.47
L
19.01
V
92.26K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Anika Therapeutics Inc Statistics

Total Valuation

Market Cap$272.61M
Enterprise Value$255.39M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding13.38M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ration/a
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-50.51
EV / Salesn/a
EV / EBITDA-62.58
EV / EBIT-46.54
EV / FCF-40.69

Financial Position

Current Ratio4.46
Quick Ration/a
Debt / Equity-0.86
Debt / EBITDA-5.83
Debt / FCF-3.79
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)18.35%
Return on Assets (ROA)-28.18%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-21,515
Employee Count235
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$235.00K
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+109.43%
50-Day Moving Average$20.31
200-Day Moving Average$14.98
Relative Strength Index (RSI)22.13
Average Volume (20 Days)80,903

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$19.00M
Operating Income-$5.49M
Pretax Income-$4.82M
Net Income-$5.06M
EBITDA-$4.08M
EBIT-$5.49M
Loss Per Share$-0.37

Balance Sheet

Cash & Cash Equivalents$41.02M
Total Debt$23.79M
Net Cash$17.23M
Net Cash Per Share$1.29
Equity (Book Value)-$27.55M
Book Value Per Share$-2.06
Working Capital$72.59M

Cash Flow

Operating Cash Flow-$2.73M
Capital Expenditures-$1.43M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$6.28M
FCF Per Share$-0.47

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield-2.30%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a